The market expects Tandem Diabetes Care, Inc. (TNDM) to deliver a year-over-year increase in earnings on higher revenues when ...

GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

The global fight against diabetes is accelerating—and diagnostic innovation is leading the charge. According to a new market study from Kalorama Information, Digital Diabetes: Global Market ...

LLY's oncology sales are expected to have climbed in Q2, led by Verzenio growth, despite pressure from older cancer drugs.

The Global Regenerative Medicine Market, valued at approximately USD 34.56 billion in 2023, is projected to witness an exponential surge, growing at a compound annual growth rate ...